Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Customer support provided helpful information when requested
Tangible Benefits Elevating NAD+ levels can influence several aspects of physical and cognitive performance
Wang X, Wang L, Xiang W
Category 1 Bulk substance the FDA considers eligible for use in compounding pending final rulemaking Generally permitted Category 2 Bulk substance the FDA has significant safety, identity, or quality concerns about Not permitted during review Category 3 Substance requiring further evaluation Case-by-case Critically, Category 1 status is not FDA approval
US$ 24.21
US$ 29.10
US$ 21.35
US$ 25.04
US$ 27.88
US$ 22.11
